Timing of ADT and Chemotherapy
Автор: Grand Rounds in Urology
Загружено: 2018-04-03
Просмотров: 1454
Thomas E. Keane, MD, explains how the current prostate cancer treatment paradigm is evolving. He discusses the optimal timing of androgen deprivation therapy (ADT), and how moving it upfront, even in a castrate sensitive setting, could benefit patients, but potentially hinder responsiveness to second-line therapies.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: